Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
PD-L1 expression is one of the most widely used immunotherapy biomarkers in clinical practice. A series of clinical research results have confirmed that the PD-L1 expression level of tumor cells and/or tumor-associated immune cells is closely related to the efficacy of immunotherapy and the prognosis of patients.